Founded in 2015 with the pursuit of human and global health, Hangzhou Testsea Biotechnology Co., Ltd. creates innovative technologies for the development of raw materials for diagnostic use.

We offer diagnostics total solutions such as rapid diagnostic tests (RDTs), fluorescent immune-diagnostic tests, ELISA, molecular diagnostic tests (MDx) and clinical chemistry.

We specialize in developing monoclonal antibodies and recombinant antigens in-house at our facility in China. We also have patented technologies including fluorescent immune diagnostics which will be one of the major IND technologies of the future.

Our facility is GMP, ISO 9001 and ISO 13485 certified and we have CE approval.